%PDF-1.4
%
61 0 obj
<>
endobj
118 0 obj
<>/Font<>>>/Fields[]>>
endobj
58 0 obj
<>
endobj
21 1 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-08T11:47:27Z
2024-03-28T07:26:14-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T07:26:14-07:00
application/pdf
Heather
200330.february
uuid:34edc29a-1dd2-11b2-0a00-000a276d7200
uuid:34edc29c-1dd2-11b2-0a00-b80000000000
endstream
endobj
47 0 obj
<>
endobj
48 0 obj
<>
endobj
62 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 31 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 33 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 37 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 39 0 R/Type/Page>>
endobj
143 0 obj
[147 0 R]
endobj
144 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(rate in diabetes mellitus. BMJ 1979;1:924-5.)Tj
-1.675 -1.25 Td
[(6.)-875.1 (Bornmyr S, Svensson H, S\232derstr\232m )17.7 (T)74 (,)-0.1 ( Sundkvist G, )17.7 (W)79.9 (ollmer P)110.7 (.)]TJ
1.675 -1.25 Td
(Finger skin blood flow in response to indirect cooling in normal)Tj
0 -1.25 TD
[(subjects and in patients before and after sympathectomy)64.8 (. Clin)]TJ
T*
(Physiol 1998;18;2:103-7.)Tj
-1.675 -1.25 Td
[(7.)-875.1 (Manthorpe R, Oxholm P)110.7 (, Prause JU, Schi\277dt MT)73.9 (. )17.7 (The Copenhagen)]TJ
1.675 -1.25 Td
[(Criteria for Sj\232gren\325)54.8 (s syndrome. Scand J Rheumatol 1986;15 Suppl)]TJ
0 Tc 0 Tw T*
(61:19-21.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875.1 (V)59.8 (itali C, Bombardieri S, Moutsopoulos HM, et al. )54.8 (Assessment of)]TJ
1.675 -1.25 Td
[(the European classification criteria for Sj\232gren\325)54.8 (s syndrome in a)]TJ
T*
(series of clinically defined cases: results of a prospective)Tj
0 Tc T*
[(multicentre study)64.9 (. )54.8 (Ann Rheum Dis 1996;55:1)36.9 (16-21.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(9.)-875.1 (Ber)17.7 (gstr\232m B, Lilja B, Rosber)17.7 (g K, Sundkvist G. )54.8 (Autonomic nerve)]TJ
1.675 -1.25 Td
(function tests. Reference values in healthy subjects. Clin Physiol)Tj
0 Tc 0 Tw T*
(1986;6:523-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(10.)-875.1 (Ber)17.7 (gstr\232m B, Lilja B, \205sterlin S, Sundkvist G. )54.8 (Autonomic)]TJ
2.175 -1.25 Td
(neuropathy in type I diabetes: Influence of duration and other)Tj
T*
[(diabetic complications. )54.8 (Acta Med Scand 1987;222:147-54.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Sundkvist G, Lilja B, )54.8 (Almer L-O. )54.8 (Abnormal diastolic blood)]TJ
2.1381 -1.25 Td
(pressure and heart rate reactions to tilting in diabetes mellitus.)Tj
T*
(Diabetologia 1980;19:433-8.)Tj
-2.175 -1.25 Td
[(12.)-875.1 (Ber)17.7 (gstr\232m B, Lilja B, \205sterlin S, Sundkvist G. )54.8 (Autonomic)]TJ
2.175 -1.25 Td
(neuropathy in non insulin dependent \(type II\) diabetes mellitus.)Tj
T*
[(Possible influence of obesity)64.8 (. J Intern Med 1990;227:57-63.)]TJ
-2.175 -1.25 Td
[(13.)-875.1 (Leden I, Lilja B, Sturfelt G, Sundkvist G. )54.8 (Autonomic nerve)]TJ
2.175 -1.25 Td
[(function in rheumatoid arthritis of varying severity)64.8 (. Scand J)]TJ
T*
(Rheumatol 1983;12:166-70.)Tj
-2.175 -1.25 Td
[(14.)-875.1 (Lindgren S, Lilja B, Rosen I, Sundkvist G. Disturbed autonomic)]TJ
2.175 -1.25 Td
[(nerve function in patients with Crohn\325)54.8 (s disease. Scand J)]TJ
T*
(Gastroenterol 1991;4:361-6.)Tj
-2.175 -1.25 Td
[(15.)-875.1 (Lindgren S, Stewenius J, Sj\232lund K, Lilja B, Sundkvist G.)]TJ
2.175 -1.25 Td
(Autonomic vagal nerve dysfunction in patients with ulcerative)Tj
T*
(colitis. Scand J Gastroenterol 1993;7:638-49.)Tj
-2.175 -1.25 Td
[(16.)-875.1 (Paschides CA, Kitsios G, Karakostas KX, Psillas C, Moutsopoulos)]TJ
2.175 -1.25 Td
[(HM. Evaluation of tear break-up time, Schirmer)-37 (\325)55.1 (s-I test and rose)]TJ
T*
(bengal staining as confirmatory tests for keratoconjunctivitis sicca.)Tj
T*
(Clin Exp Rheumatol 1989;7:155-7.)Tj
30.825 45 Td
[(17.)-875.1 (van Bijsterveld OP)110.7 (. Diagnosis and dif)17.7 (ferential diagnosis of)]TJ
2.175 -1.25 Td
(keratoconjunctivitis sicca associated with tear gland degeneration.)Tj
T*
(Clin Exp Rheumatol 1990;8 Suppl 5:3-6.)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Manthorpe R, )54.8 (Ax\216ll )17.7 (T)74 (. Xerostomia. Clin Exp Rheumatol 1990;8)]TJ
2.175 -1.25 Td
(Suppl 5:7-12.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (Ber)17.7 (gstr\232m B, Mattiasson I, Rosen I, Lilja B, Sundkvist G. Platelet)]TJ
2.175 -1.25 Td
[(sodium and potassium )54.8 (A)110.8 (TPase activity and noradrenaline ef)17.7 (flux)]TJ
T*
(rate in relation to autonomic and peripheral nerve function in)Tj
T*
(insulin dependent diabetic patients. J Intern Med 1989;225:185-90.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (Ber)17.7 (gstr\232m B, Manhem P)110.7 (, Bramnert M, Lilja B, Sundkvist G.)]TJ
2.175 -1.25 Td
(Impaired responses of plasma catecholamines to exercise in)Tj
T*
(diabetic patients with abnormal heart reactions to tilt. Clin Physiol)Tj
0 Tc 0 Tw T*
(1989;9:259-67.)Tj
-0.00011 Tc 0.00729 Tw -2.175 -1.25 Td
[(21.)-875.1 (Skopouli )-17.8 (FN, T)69.9 (alal )37.1 (A, )-17.8 (Galanopoulou V)128.9 (,)-0.1 ( T)69.9 (sampoulas )-17.7 (CG, )-17.7 (Drosos)]TJ
0.02499 Tw 2.175 -1.25 Td
[(AA, Moutsopoulos HM. Raynaud\325)54.8 (s phenomenon in primary)]TJ
T*
[(Sj\232gren\325)54.8 (s syndrome. J Rheumatol 1990;17:618-20.)]TJ
-2.175 -1.25 Td
[(22.)-875.1 (Kraus )54.8 (A, Caballero-Uribe C, Jakez J, )17.7 (V)59.8 (illa )54.8 (AR, )54.8 (Alarc\227n-Segovia D.)]TJ
2.175 -1.25 Td
[(Raynaud\325)54.8 (s phenomenon in primary Sj\232gren\325)54.8 (s syndrome.)]TJ
T*
(Association with other extraglandular manifestations. J Rheumatol)Tj
0 Tc 0 Tw T*
(1992;19:1572-4.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(23.)-875.1 (Engelhart M, Kristensen JK. Raynaud\325)54.8 (s phenomenon: blood supply)]TJ
2.175 -1.25 Td
(to fingers during indirect cooling, evaluated by laser Doppler)Tj
T*
[(flowmetry)64.9 (. Clin Physiol 1986;6:481-8.)]TJ
-2.175 -1.25 Td
[(24.)-875.1 (Cof)17.7 (fman JD. Raynaud\325)54.8 (s phenomenon \321 )54.8 (An update. Hypertension)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(1991;17:593-602.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(25.)-875.1 (Gustavsson R, Mannting F)79.7 (, Kazzam E, )17.7 (W)79.9 (aldenstr\232m )54.8 (A, H\212llgren R.)]TJ
2.175 -1.25 Td
(Cold-induced reversible myocardial ischaemia in systemic)Tj
T*
(sclerosis. Lancet 1989;1:475-9.)Tj
-2.175 -1.25 Td
[(26.)-875.1 (Lekakis J, Mavrikakis M, Emmanuel M, et al. Cold-induced)]TJ
2.175 -1.25 Td
[(coronary Raynaud\325)54.8 (s phenomenon in patients with systemic)]TJ
T*
(sclerosis. Clin Exp Rheumatol 1998;16:135-40.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (Bornmyr S, Castenfors J, Svensson H, )17.7 (W)39.8 (roblewski M, Sundkvist G,)]TJ
2.175 -1.25 Td
[(W)79.9 (ollmer P)110.7 (. Detection of autonomic sympathetic dysfunction in)]TJ
T*
[(diabetic patients \321 )54.8 (A)-220.1 (study using laser Doppler imaging. Diabetes)]TJ
T*
(Care 1999;22:593-7.)Tj
-2.175 -1.25 Td
[(28.)-875.1 (Engelhart M. )17.7 (The ef)17.7 (fect of sympathetic blockade and cooling in)]TJ
0 Tc 2.175 -1.25 Td
[(Raynaud\325)54.9 (s phenomenon. Clin Physiol 1990;10:131-6.)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
-0.00011 Tc 8 0 0 8 54.5 35.9844 Tm
(Mandl, et al: Sympathetic dysfunction in pSS)Tj
0 Tc 0 Tw 61.4375 -0.0313 Td
(301)Tj
ET
0 0 0 0 k
/GS0 gs
102.47 59.08 407.5 -10.83 re
f*
0.5 w
102.47 59.08 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
39 0 obj
<>stream
8;Z\7!KP&O#kS'\aELB\"WL@nAm7@Q8U/_8,q6f`8S6Oer&;Ckf^FS?c!jmc4q(b,
D[H?o(1H".IJ^?ua]RXlKj2GBg3+tdJ^JJ,gtm+ZYuDde%uaXtC&+1INr`>toAoY?
$P:.=9b5jcjH-:9I(BR'hk6`:AB8#c8<"MbG)CU;11]l6#/j@0UCdE$;7'%n3[
<=LgLVC@9sYm2h.%=]XOKTtb1LG\fVF3V9teN:YR';/6VH9cN;<"tNNM$,(L"q%d/
HruW":R)N\3aNYUl*ZfspNP!M$KKIKR$!,Vc/M*LSX!JA[X]cf`,YWV(KP?Al;G_@
ABsd@"t(b*KdC;[1"sI?OR$YM4-9/H+.pEY;I<+dVhqOKp2/Rf$Q5&.FA04((^6Lh
JuVm$KO_f-aKCclImJ[JEZ&sukD@i/:uu[_rSqL2Xa/9nKbQ*p#,K=<7,P0HE's\M
90)EEYqt3_*XuDP.e]FNWXh[``Q9`.#'1g:"BcHbOnu'o$o:KB4p^h:]'X26jb]`B
]d+:)l*W-J;R9sBMX]cQEsICd>H;m=h\B("7cqF"Oi4RKa!2e-a1jmLd:b?TNCK\j
pj9dq\Aub&`Ok@(D\F]$$!P!PnIC!P!+BX32u~>
endstream
endobj
45 0 obj
[/Indexed/DeviceRGB 255 44 0 R]
endobj
44 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
68 0 obj
<>
endobj
65 0 obj
<>
endobj
103 0 obj
<>
endobj
126 0 obj
<>
endobj
64 0 obj
<>
endobj
96 0 obj
<>stream
H{PSWr(`Pn}wDK[*REDEyHA" Lx#AĈ |,wQ+*eLqؙu蜙ߜ;8fi8nubHU%>.bα`,˹#<<ϒu٢uHW.9g~Bx`U \.Hwpvqqu(rfɁk>].kaP[!$2fki\4.D.
sfQQ̤Vĉd$1#1!<.$L$ ;H2^h\#b6z2!a˥qxB'!qb7{0lfE`l}Lb.8 m211mh F`$K w+,4F8,S-NRN)W͡pj
M>}ꜩӸ
x*/hF܌3[j0z+kBHcۭYg%;f>^1 8|Zڎ^I4 YH5*OKedY*ECehU!Q%1..|t4>>?%tRc|CoJs&l^.
p@D}ƢG=z7J:+]r1XBXŴxR-_?!C>,x#1<dΉx m^Nk-4W
Uj2sӴ"DyPo7銎:j`"j dS$G(FO5lU<8$wTX!~X{EgEdxl&feJ)6m
5;Ө3܀Ƣe/=U1*QZ/.Tg3KKTX!`9ќ-5] 4 M߁qh#tƎ5AW(vesbXד+[Ôg3\թ?(/DR7)
4hw(*PZv\SuXMՈ!M(҇2QgqM'}I)QIʺ
Gw߳j64w_IH
LxT#%0֍>྾s4{1/=$)5v%4OϘ-(H2Ϧ_,9@$~_./K(>2;Jt<&:<3_eO?9qw|#<,|Dv2J[#CeJbbd YHԠE^$uYxt"v܂ѧD~UoA뗐6Jy 6fxES$(ȅm``1_S`ʆ3Mvµ[i6B[K+r-v坃,4vb;[1~~Ց~ۓ7S56Q|˲mx049%>evϓ)~h6u@prƲo*)[D7m
L9`{'ƥN9A$W8{0x
K+oz{{ai<4Zp ZU*uѲOR3t.+NAw+ZC\/ޣu%
~PdiM܁L[!ԡqsOrr\±.+udzѬ\DډyQʉgazbţ"II'H-oKi|WJ7_WkPSgIg7xٺեJ*WH-܀$ !$p5\DP-RXu]T]|gOpi9<}azp-`Z\?4b76O^m
4?o` Q&>Bep,%o],f́!.b
5+jLBip
W89a;'[P_p